Regulatory T cells/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodialysis: A pivotal link between microinflammation and adverse cardiovascular events: Original Article

Nephrology

Volumn 15, Issue 1, 2010, Pages 33-41

  Zhang, Jianbin ^a   Hua, Gan ^a   Zhang, Xiaogang ^a   Tong, Ruyan ^b   Du, Xiaogang ^a   Li, Zhengrong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Affiliated Hospital   (China)

Author keywords

Adverse cardiovascular events; Atherosclerosis; Chronic kidney disease; Maintenance haemodialysis; Microinflammation; Regulatory T cells T helper cell 17

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 16; INTERLEUKIN 17; MESSENGER RNA; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS; HUMAN; MALE; MICROINFLAMMATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH17 CELL; TURBIDIMETRY; UREMIA;

ADULT; AGED; ATHEROSCLEROSIS; FEMALE; HUMANS; INFLAMMATION; KIDNEY DISEASES; MALE; MIDDLE AGED; RENAL DIALYSIS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; UREMIA;

EID: 77149139127     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01172.x     Document Type: Article

References (24)

1. Bonello L, De Labriolle A, Rov P et al. Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome. Am. J. Cardiol. 2008 102 : 535 540.
2. Stenvinkel P, Alrestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy [J]. Semin. Dial. 2002 15 : 329 337.
3. Sherer Y, Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat. Clin. Pract. Rheumatol. 2006 2 : 99 106.
4. Blasi C. The autoimmune origin of atherosclosclerosis. Atherosclerosis 2008 5 : 1 13.
5. Binder CJ, Chang MK, Shaw PX et al. Innate and acquired immunity in atherogenesis. Nat. Med. 2002 8 : 1218 1226.
6. Lonnemann G. Should ultra-pure dialysate be mandatory? Nephrol. Dial. Tranaplant. 2000 15 (Suppl 1 55 9.
7. Wanner C, Zimmermann J, Schwedler S, Metzger T. Inflammation and cardiovascular risk in dialysis patients. Kidnry Int. 2002 80 (Suppl 3 S99 102.
8. Mucida D, Park Y, Kim G et al. Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007 317 : 256 260.
9. Sakaguchi S, Ono M, Setoguchi RH et al. Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 2006 212 : 8 27.
10. Homey B. After Th1/Th2 now comes Treg/Th17: significance of T helper cells in immune response organization. Hautarzt 2006 57 : 730 732.
11. Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum. 2008 58 : 2196 2205.
12. Libby P. Inflammation in atherosclerosis. Nature 2002 420 : 868 874.
13. Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 2002 91 : 281 291.
14. Cheng X, Yu X, Ding Y et al. The Th17/Treg imbalance in patients with acute coronary syndromr [J]. Clin. Immunol. 2008 127 : 89 97.
15. Mahajan D, Wang Y, Qin X et al. CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease. J. Am. Soc. Nephrol. 2006 17 : 2731 2741.
16. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 2007 8 : 345 350.
17. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004 21 : 467 476.
18. Michon I, De Vos P, Van Wanrooij E, Van Berkel T, Kuiper J. Division of Biopharmaceutics, Netherlands. The role of IL-17 in atherosclerotic lesion formation in mice. XIIIth International Symposium on Atherosclerosis, 28 September-2 October 2003, Kyoto, Japan.
19. Csiszar A, Ungvari Z. Synergistic effects of vascular IL-17 and TNF-α may promote coronary artery disease. Med. Hypotheses 2004 63 : 696 698.
20. Mallaat Z, Ait-Oufella H, Tedgui A. Regulatory T cell immunity in atherosclosis. Trends Cardiovasc. Med. 2007 17 : 113 118.
21. Mor A, Planer D, Luboshits G et al. Role of naturally occurring CD4+CD25+ regulatory T cell in experimental atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2007 27 : 893 900.
22. Schubert LA, Jeffery E, Zhang Y. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. Biol. Chem. 2001 276 : 37672 37679.
23. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006 441 : 235 238.
24. Venet F, Pachot A, Debard A-L et al. Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. Immunology 2006 177 : 6540 6547.